Julien Rongère
General Counsel bei AC IMMUNE SA
Ursprung des Netzwerks ersten Grades von Julien Rongère
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Julien Rongère
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Doctorate Degree | |
| BIOMÉRIEUX | Medical Specialties | Director of Finance/CFO | |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Medical Specialties | Corporate Officer/Principal | |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of Vienna | College/University | Doctorate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Milan | College/University | Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bern | College/University | Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree | |
Nestlé Nespresso SA
 Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Industrial Machinery | Corporate Officer/Principal | |
| Medical College of Virginia | College/University | Doctorate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree | |
Pantec Biosolutions AG
 Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Drugstore Chains | Director/Board Member | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| NOVIMMUNE SA | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder Founder | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Chairman | |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Schweiz | 22 |
| Vereinigte Staaten | 9 |
| Deutschland | 8 |
| Österreich | 4 |
| Italien | 3 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 14 |
| Finance | 5 |
| Producer Manufacturing | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 105 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 27 |
| Chairman | 25 |
| Chief Tech/Sci/R&D Officer | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Alan Colowick | 27 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Werner Lanthaler | 12 |
| Thomas Graney | 11 |
| Andrea Pfeifer | 11 |
| Carl June | 9 |
| Gary Waanders | 8 |
| Monica Shaw | 8 |
| Wolfgang Barth | 7 |
| Marie Kosco-Vilbois | 7 |
| Sonia Maria Poli | 7 |
| Roy Ervin Twyman | 6 |
- Börse
- Insiders
- Julien Rongère
- Unternehmensverbindungen
